CEO View | Reflecting on UKRI’s first five year strategy

CEO View | Reflecting on UKRI’s first five year strategy

In this blog post our CEO offers some opinions on UK Research and Innovation's strategy. This was first published by the BioIndustry Association.

Addressing current challenges of in vitro cell models

Addressing current challenges of in vitro cell models

In this blog, learn about current challenges of hiPSC-derived cell models, best approach for cell generation & future trends for human cell models.

CEO View | SynBio: the opportunity for UK Life Sciences

CEO View | SynBio: the opportunity for UK Life Sciences

Our CEO writes about the importance of the synthetic biology industry as part of the UK Life Sciences vision. This was first published by the BioIndustry Association.

CEO Views | Business and academia - the perfect partners to achieve SDGs

CEO Views | Business and academia - the perfect partners to achieve SDGs

Our CEO reflects on a recent UN High-Level Political Forum discussion about industry & academia collaborations to achieve sustainable development goals.

CEO View | Why did I start a healthcare and cultured meat company?

CEO View | Why did I start a healthcare and cultured meat company?

Our CEO explains how our opti-ox technology underpins not only bit.bio but also Meatable - a cultured meat company — and why we need to rethink sustainability.